Previous Close | 0.3004 |
Open | 0.2978 |
Bid | 0.2942 x 800 |
Ask | 0.3058 x 1100 |
Day's Range | 0.2900 - 0.3142 |
52 Week Range | 0.2400 - 1.8600 |
Volume | |
Avg. Volume | 936,288 |
Market Cap | 77.348M |
Beta (5Y Monthly) | 1.89 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VBI Vaccines ( NASDAQ:VBIV ) Full Year 2022 Results Key Financial Results Net loss: US$113.3m (loss widened by 62% from...
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of -14.29% and 85.20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
To get a sense of who is truly in control of VBI Vaccines Inc. ( NASDAQ:VBIV ), it is important to understand the...